Pain management company SPR Therapeutics yesterday said it won FDA 510(k) clearance for its Sprint peripheral nerve stimulation system designed to provide chronic pain relief. The Cleveland, Ohio-based company touted the Sprint system as the 1st reversible and minimally-invasive PNS to win FDA clearance for treating chronic and acute pain, including post-operative and post-traumatic pain. […]
Pain Management
Relievant Medsystems wins FDA clearance for Intracept ablation device for low back pain
Relievant Medsystems said today it won FDA 510(k) clearance for its Intracept intraosseous nerve ablation system designed for the treatment of chronic lower back pain. The company touted the system as the 1st specific therapy to relieve chronic lower back pain which has persisted for at least 6 months and not responded to conservative care […]
Bayer launches over-the-counter Aleve TENS pain device
Bayer (ETR:BAYN) said today it launched the Aleve direct therapy targeted transcutaneous electrical nerve stimulation pain relief device in the U.S. The device is designed as a non-invasive, drug-free method of pain control, specifically targeted at lower back pain, according to the company. “Aleve Direct Therapy puts controllable TENS technology in consumers hands without having to […]
Nexstim wins CE Mark for brain therapy treatment for chronic neuropathic pain
Brain therapy system developer Nexstim said late last month it won expanded CE Mark approval in the European Union for its Navigated Brain Therapy system, now cleared for the relief of chronic neuropathic pain. The NBT system uses navigated transcranial magnetic stimulation to treat exact areas in the brain using a 3D image rendered from […]
AtriCure launches cryoanalgesia study
AtriCure (NSDQ:ATRC) said today it launched and enrolled the 1st patient in the Frost trial which aims to examine the use of its CryoIce system designed for the cryoablation of peripheral nerves for the temporary management of post-operative pain. The trial is slated to enroll up to 100 patients to explore the use of cryoanalgesia in addition […]
Mainstay Medical pulls in $34m for Reactiv8 neurostim device for chronic pain
Mainstay Medical (EPA:MSTY) said last week that it raised a $34 million (€30 million) equity round for its Reactiv8 neurostimulation device, including a $17 million (€15 million) contribution from family investment fund KCK. Proceeds from the 2.3-million-share flotation, priced at $14.70 apiece (€13.00), are slated for European commercialization of the Reactiv8 device (the system won CE Mark approval in […]
NeuroMetrix closes $21.3m funding round
NeuroMetrix (NSDQ:NURO) said yesterday it closed a $21.3 million round of funding through the private placement of preferred stock and warrants to support its Quell wearable pain relief device for patients with chronic pain. The Waltham, Mass.-based company said it sold 21,300 shares of Series D convertible preferred stock at $1,000 per share and warrants to […]
Milestone Scientific touts CompuFlo trial completion, plans FDA submission
Milestone Scientific‘s (OTC:MLSS) said today it completed the pivotal study of its CompuFlo epidural computer controlled system, investigating the safety and efficacy of the epidural space verification of the system. The 400-patient, multicenter pivotal Compass study looked to compare treatment with the CompuFlo device against the current standard of care for patients undergoing pain management and […]
NeuroMetrix jumps on $21m round as Quell pain device hits 1k retail stores
NeuroMetrix (NSDQ:NURO) shares jumped yesterday after the company announced a $21 million private placement and said its Quell pain relief device is on the shelves at 1,000 retail drug stores. The private placement of 21,300 Series C shares at $1,000 apiece went to an institutional investor dedicated to backing healthcare companies, Waltham, Mass.-based NeuroMetrix said. The […]
NeuroMetrix launches Quell Health Cloud on Android
NeuroMetrix (NSDQ:NURO) said today it launched its Quell Health Cloud for Google‘s (NSDQ:GOOG) Android device platform. The newly launched Health Cloud app allows users of Quell devices to set up accounts where data from their devices are automatically backed-up to secure storage. “We are excited to add Health Cloud capabilities to our Android app. We’ve already […]
FDA approves Boston Scientific’s Precision Montage MRI-safe spinal cord stimulator
Boston Scientific (NYSE:BSX) said it won FDA approval for its Precision Montage MRI-safe spinal cord stimulator for chronic pain and plans to launch the device tomorrow. The Precision Montage MRI SCS is cleared for full-body, 1.5 Tesla MRI scans, the Marlborough, Mass.-based company said. It’s designed to deliver multiple waveforms so patients can tailor their therapy as their pain […]